Phase 1 Delivery Clinical Trials
5 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–5 of 5 trials
Recruiting
Phase 1
First in Human Safety and Ease of Use Assessment of 400mg Progesterone Callavid in Women With Luteal Phase Insufficiency
Luteal Phase InsuffiencyProgesterone Delivery
Calla Lily Clinical Care Ltd20 enrolled1 locationNCT07136922
Recruiting
Phase 1Phase 2
Vaginal Microbiome Seeding and Health Outcomes in Cesarean-delivered Neonates.
Obesity, ChildhoodCesarean Delivery Affecting Newborn
National Institute of Allergy and Infectious Diseases (NIAID)600 enrolled1 locationNCT03298334
Recruiting
Phase 1Phase 2
Intrathecal PD-1/VEGF Bispecific Antibody Plus Pemetrexed for Leptomeningeal Metastasis
Leptomeningeal MetastasisIntrathecal Drug Delivery
Guangzhou Medical University34 enrolled1 locationNCT06809517
Completed
Phase 1
A first-in-human study to evaluate the safety, tolerability and performance of uncoated and placebo-coated Nanopatches
Vaccination Delivery Device
Vaxxas Pty Ltd18 enrolled1 locationACTRN12615000583549
Completed
Phase 1
A proof of concept study comparing the skin penetration abilities of the novel penetration enhancer Tocopheryl Phosphate Mix (TPM)/Diclofenac compared with Voltaren Gel
Transdermal drug delivery
Phosphagenics Limited12 enrolled1 locationACTRN12608000574347